Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 545741 - 545760 out of 553696 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FF02) pembrolizumab (adm: P) | KEYTRUDA 100MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&DohmeLLC |
| USA | (L01FF02) pembrolizumab (adm: P) | KEYTRUDA 100MG INJ | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&DohmeLLC |
| USA | (L01FF02) pembrolizumab (adm: P) | KEYTRUDA 100MG INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&DohmeLLC |
| USA | (L01FF02) pembrolizumab (adm: P) | KEYTRUDA 100MG INJ | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Endometrial Neoplasms | MerckSharp&DohmeLLC |
| USA | (L01FF03) durvalumab (adm: P) | IMFINZI 120MG INJ | 120MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF03) durvalumab (adm: P) | IMFINZI 120MG INJ | 120MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF03) durvalumab (adm: P) | IMFINZI 500MG INJ | 500MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF03) durvalumab (adm: P) | IMFINZI 500MG INJ | 500MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF04) avelumab (adm: P) | BAVENCIO (AVELUMAB) INJECTION 20MG/ML | 1X10VI | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | EMDSerono,Inc. |
| USA | (L01FF04) avelumab (adm: P) | BAVENCIO (AVELUMAB) INJECTION 20MG/ML | 1X10VI | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | EMDSerono,Inc. |
| USA | (L01FF05) atezolizumab (adm: P) | TECENTRIQ HYBREZA | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L01FF05) atezolizumab (adm: P) | TECENTRIQ/1200MG/20ML(60MG/ML)SDV | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | GenentechUSA,Inc. |
| USA | (L01FF05) atezolizumab (adm: P) | TECENTRIQ/1200MG/20ML(60MG/ML)SDV | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | GenentechUSA,Inc. |
| USA | (L01FF05) atezolizumab (adm: P) | TECENTRIQ 840MG/14ML(60MG/ML)SDV | 14ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | GenentechUSA,Inc. |
| USA | (L01FF05) atezolizumab (adm: P) | TECENTRIQ 840MG/14ML(60MG/ML)SDV | 14ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | GenentechUSA,Inc. |
| USA | (L01FF06) cemiplimab (adm: P) | LIBTAYO 50MG/ML INJ,VIL,7ML | 1X7ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | RegeneronPharmaceuticals,Inc. |
| USA | (L01FF06) cemiplimab (adm: P) | LIBTAYO 50MG/ML INJ,VIL,7ML | 1X7ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | RegeneronPharmaceuticals,Inc. |
| USA | (L01FF07) dostarlimab | JEMPERLI 50MG/ML | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GlaxoSmithKline |
| USA | (L01FF07) dostarlimab | JEMPERLI 50MG/ML | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GlaxoSmithKline |
| USA | (L01FF13) toripalimab | LOQTORZI 40MG/ML INJ,SOLN | 6ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Nasopharyngeal Carcinoma;Esophageal Squamous Cell Carcinoma | CoherusBioSciences,Inc. |
Pages
